Arcellx (ACLX) Return on Capital Employed (2022 - 2025)
Arcellx's quarterly Return on Capital Employed came in at 9.14% in Q4 2025, up 3159.0% year-on-year from 0.28% in Q4 2024, and up 119.56% quarter-over-quarter from 46.72% in Q3 2025.
Arcellx has reported Return on Capital Employed for 4 years, with the latest figure at 9.14% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 3159.0% year-over-year to 9.14%; the trailing twelve-month figure through Dec 2025 stood at 9.14% (up 3159.0% YoY), and the FY2025 full-year result was 8.68%, up 3008.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 9.14%, up from 46.72% in the prior quarter.
- The five-year high for Return on Capital Employed was 9.14% in Q4 2025, with the low at 71.13% in Q4 2022.
- Average Return on Capital Employed over 4 years is 33.06%, with a median of 33.38% recorded in 2025.
- Year-over-year, Return on Capital Employed soared 5619 bps in 2023 and sank 3539 bps in 2025.
- Tracing ACLX's Return on Capital Employed over 4 years: stood at 71.13% in 2022, then jumped by 79 bps to 14.94% in 2023, then sank by 50 bps to 22.45% in 2024, then surged by 141 bps to 9.14% in 2025.
- The last three Return on Capital Employed figures came in at 9.14% (Q4 2025), 46.72% (Q3 2025), and 41.9% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 9.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.14% |
| Sep 30, 2025 | -46.72% |
| Jun 30, 2025 | -41.90% |
| Mar 31, 2025 | -33.61% |
| Dec 31, 2024 | -22.45% |
| Sep 30, 2024 | -11.33% |
| Jun 30, 2024 | -12.06% |
| Mar 31, 2024 | -10.83% |
| Dec 31, 2023 | -14.94% |
| Sep 30, 2023 | -32.51% |
| Jun 30, 2023 | -41.51% |
| Mar 31, 2023 | -64.71% |
| Dec 31, 2022 | -71.13% |
| Sep 30, 2022 | -55.25% |
| Jun 30, 2022 | -33.16% |
| Mar 31, 2022 | -46.02% |